EO9: A novel bioreductive alkylating indoloquinone with preferential solid tumour activity and lack of bone marrow toxicity in preclinical models

Authors:
  • PPP.E. Pizao
    P.E. Pizao
  • DBD.P. Berger
    D.P. Berger
  • KKK.L. Kooistra
    K.L. Kooistra
  • MBM.C. Bibby
    M.C. Bibby
  • EBE. Boven
    E. Boven
  • HMH.C. Dreef-Van der Meulen
    H.C. Dreef-Van der Meulen
  • RHR.E.C. Henrar
    R.E.C. Henrar
  • HFH.H. Fiebig
    H.H. Fiebig
  • JDJ.A. Double
    J.A. Double
  • HHH.W. Hornstra
    H.W. Hornstra
  • HPH.M. Pinedo
    H.M. Pinedo

Abstract
No abstract available

This publication has 25 references indexed in Scilit: